Architectural rendering of our new building currently under construction on Memorial Healthcare’s main campus
Have you heard the news? We’ve been featured in Detroit Crain’s Business and multiple news stations, research magazines, and newspapers from across the country!
Memorial Healthcare is the first in the United States to use neurofilament light (NfL) technology clinically for Multiple Sclerosis patients. “Once the blood test is approved it will completely change the way we practice neurology in the world, for not only MS, but also dementia and Alzheimer’s disease,” says Dr. Rany Aburashed, Chief of Neurology at the Institute for Neurosciences and MS at Memorial.
- The Sociable – What the ‘biomarker revolution’ means for personalized, precision medicine
- Crain’s Detroit Business – Hospital plots leadership path in MS research
- Crain’s Detroit Business Article – How a rural hospital became a neurology hub and stayed independent
- Multiple Sclerosis News Today – Michigan’s Memorial Healthcare first in US to fest NfL in MS patients
- ABC12 – Memorial Healthcare first to use NfL testing on patients with neurological conditions
- The Argus Press – MS testing puts Memorial at forefront of research
ABC12 HealthSource Features:
- Dr. Jeanie Cote – Multiple Sclerosis
- Dr. Margaret Frey – SMA/Spinraza
- Dr. Ali Saeed – Stroke Awareness
- Dr. Rany Aburashed and Dr. Robert Pace – Multiple Sclerosis
- Dr. Cara Leahy – Memory Care
Click here for a story from FOX2 Detroit featuring Dr. Rany Aburashed and his work with Multiple Sclerosis.
At the Memorial Healthcare Institute for Neuroscience, we are passionate about delivering the very best care possible and take the time to understand each patient’s unique diagnosis and needs.
We believe in truly personalized care, delivered by experts trained in the complexities of a variety of difficult-to-understand neurological diseases and conditions.
Memorial Healthcare’s Institute for Neuroscience is world-renowned in the neurology field. Since 2015, Memorial Healthcare has been the first, or one of the first, hospitals in the State of Michigan to administer drug therapy treatments for its patients including Lemtrada (for MS), Ocrevus (for MS), Radicava (ALS), and Spinraza (for Spinal Muscular Atrophy). The Center offers patients the latest technology advances including NeuroQuant, a software that analyzes a brain MRI to improve the early detection and treatment of MS, dementia, Alzheimer’s disease, and epilepsy. Additionally, Memorial Healthcare is one of just three MDA care clinics in the State of Michigan.
The Institute was the first center in Michigan to receive designation as a Partner in Multiple Sclerosis Care/Neurological Care from the Michigan Chapter of the National Multiple Sclerosis Society. Our highly skilled and experienced specialists handle the most complex MS cases with a patient load of over 2,400. We utilize the most advanced MRI technology in MS care and we are also home to MS research and clinical trials.
- Partner in MS Care/National Multiple Sclerosis Society
- MDA/ALS Care Center
Services and Conditions Treated:
- EEG & EMG
- Movement disorders
- Multiple Sclerosis
- Neuromuscular diseases
- Ocular Motor Oto-Neurology
- Parkinson’s Disease
- Peripheral Neuropathies
- Stroke management
- and much more
Our providers are currently accepting new patients with most insurances.
Memorial Healthcare Institute for Neuroscience is an employed physician practice of Memorial Medical Associates, a department of Memorial Healthcare.